MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China – August 6, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. Highlights for Second Quarter 2012 • Net revenues were $267.8 million, an increase of 23.3%]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2012 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China – August 6, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. Highlights for Second Quarter 2012 • Net revenues were $267.8 million, an increase of 23.3%]

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. RECEIVES APPROVAL FROM XIANYANG SFDA

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTART SALES OF ITS GEL CAPSULE DRUGS XIANYANG, China, August 3, 2012 - Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that on July 30, 2012, after]

By | 2016-03-03T11:56:01+00:00 August 6th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million,]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2012 Financial Results STYLE=”font-family:Times

[Mindray Announces Second Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million,]

YGE [YINGLI GREEN ENERGY CO] 6-K: (Original Filing)

[Yingli Green Energy Preannounces Financial Results for Second Quarter 2012 BAODING, China; August 2, 2012 — Yingli Green Energy Holding Company Limited (NYSE: YGE) (“Yingli Green Energy” or the “Company”), a leading solar energy company and one of the world’s largest vertically integrated photovoltaic (“PV”) manufacturers, which markets its products under the brand “Yingli Solar,” today preannounced its financial results]

By | 2016-02-28T18:04:19+00:00 August 6th, 2012|Categories: Chinese Stocks, SEC Original, YGE|Tags: , , , , , |0 Comments
Skip to toolbar